Takayasu's Arteritis Clinical Trials
3 recruiting trials for Takayasu's Arteritis. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Takayasu's Arteritis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Beijing Institute of Heart, Lung and Blood Vessel Diseases (1), University of Pennsylvania (1), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1), among the most active sponsors registered for these trials.
Track Takayasu's Arteritis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)
Takayasu arteritis is a chronic vasculitis mainly involving the aorta and its main branches such as the brachiocephalic, carotid, subclavian, vertebral, and renal arteries, as...
One-Time DNA Study for Vasculitis
The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of...
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Background: \- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose the disease, and...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Takayasu's Arteritis, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Takayasu's Arteritis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Takayasu's Arteritis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.